Hematopoietic Stem Cell Mobilization
📧 Sign up to get email alerts when something new happens for Hematopoietic Stem Cell Mobilization.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2025-11-25EMA Authorised: Accofil (filgrastim) — Accord Healthcare S.L.U.
The European Medicines Agency authorised Accofil, a filgrastim biosimilar from Accord Healthcare S.L.U., for EU marketing to prevent chemoth…
-
CLINICAL_TRIALS trial_result · 2020-05-18Clinical Trial Update: Meloxicam vs Placebo for Mobilization [Phase 2]
Phase 2 trial comparing Meloxicam to placebo for mobilization in hematologic malignancies has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-12-06Clinical Trial Update: Recombinant Human Thrombopoietin for Mobilization of Peripheral Blood Progenitor Cells for Autologous Transplantation [Phase 1, Phase 2]
A clinical trial update describes the investigation of recombinant human thrombopoietin for mobilizing peripheral blood progenitor cells in …